| Dr Sanjiv Upadhyay, MD | |
|
2040 Ogden Ave, Suite 301, Aurora, IL 60504-7222 | |
| (630) 978-6895 | |
| (630) 753-2905 |
| Full Name | Dr Sanjiv Upadhyay |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 33 Years |
| Location | 2040 Ogden Ave, Aurora, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215987961 | NPI | - | NPPES |
| 036107658 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 036107658 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Copley Memorial Hospital | Aurora, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rush-copley Medical Group Nfp | 7618864877 | 108 |
News Archive
Passive immunization through the development of fully human antibodies specific to Plasmodium falciparum may be effective at controlling the disease, report researchers led by Dr. Richard S.
Marblar is gamifying the process of technology transfer. We post technology on our platform in the form of a challenge, and the Marblar community then competes to uncover new problems these technologies could solve – thereby discovering new market applications for these technologies.
How genes affect intelligence is complicated. Multiple genes, many yet unknown, are thought to interact among themselves and with environmental factors to influence the diverse abilities involved in intelligence.
In this post in the Guardian's "Poverty Matters" blog, Johanna Ralston, chief executive of the World Heart Federation, and Ann Keeling, chief executive of the International Diabetes Federation, argue non-communicable diseases (NCDs) must be part of any new global development goals, writing, "NCDs and their risk factors worsen poverty, while poverty contributes to rising rates of NCDs, posing a threat to sustainable development."
In a novel proof of concept study, published on the bioRxiv preprint server, U.S. researchers used attenuated influenza viral particles that express severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain to induce neutralizing antibodies in mice – unveiling another viable vaccine candidate for preventing coronavirus disease (COVID-19).
› Verified 3 days ago
| Entity Name | Rush-copley Medical Group Nfp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093075848 PECOS PAC ID: 7618864877 Enrollment ID: O20040310001029 |
News Archive
Passive immunization through the development of fully human antibodies specific to Plasmodium falciparum may be effective at controlling the disease, report researchers led by Dr. Richard S.
Marblar is gamifying the process of technology transfer. We post technology on our platform in the form of a challenge, and the Marblar community then competes to uncover new problems these technologies could solve – thereby discovering new market applications for these technologies.
How genes affect intelligence is complicated. Multiple genes, many yet unknown, are thought to interact among themselves and with environmental factors to influence the diverse abilities involved in intelligence.
In this post in the Guardian's "Poverty Matters" blog, Johanna Ralston, chief executive of the World Heart Federation, and Ann Keeling, chief executive of the International Diabetes Federation, argue non-communicable diseases (NCDs) must be part of any new global development goals, writing, "NCDs and their risk factors worsen poverty, while poverty contributes to rising rates of NCDs, posing a threat to sustainable development."
In a novel proof of concept study, published on the bioRxiv preprint server, U.S. researchers used attenuated influenza viral particles that express severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain to induce neutralizing antibodies in mice – unveiling another viable vaccine candidate for preventing coronavirus disease (COVID-19).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sanjiv Upadhyay, MD 2040 Ogden Ave Ste 301, Aurora, IL 60504-7205 Ph: (630) 978-6895 | Dr Sanjiv Upadhyay, MD 2040 Ogden Ave, Suite 301, Aurora, IL 60504-7222 Ph: (630) 978-6895 |
News Archive
Passive immunization through the development of fully human antibodies specific to Plasmodium falciparum may be effective at controlling the disease, report researchers led by Dr. Richard S.
Marblar is gamifying the process of technology transfer. We post technology on our platform in the form of a challenge, and the Marblar community then competes to uncover new problems these technologies could solve – thereby discovering new market applications for these technologies.
How genes affect intelligence is complicated. Multiple genes, many yet unknown, are thought to interact among themselves and with environmental factors to influence the diverse abilities involved in intelligence.
In this post in the Guardian's "Poverty Matters" blog, Johanna Ralston, chief executive of the World Heart Federation, and Ann Keeling, chief executive of the International Diabetes Federation, argue non-communicable diseases (NCDs) must be part of any new global development goals, writing, "NCDs and their risk factors worsen poverty, while poverty contributes to rising rates of NCDs, posing a threat to sustainable development."
In a novel proof of concept study, published on the bioRxiv preprint server, U.S. researchers used attenuated influenza viral particles that express severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain to induce neutralizing antibodies in mice – unveiling another viable vaccine candidate for preventing coronavirus disease (COVID-19).
› Verified 3 days ago
Robert J Nudera, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 2040 Ogden Ave, Suite 301, Aurora, IL 60504 Phone: 630-978-6895 Fax: 630-375-2905 | |
Stephen M Kelanic, M.D., F.A.C.S. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2040 Ogden Ave Ste 301, Aurora, IL 60504 Phone: 630-978-6895 Fax: 630-375-2905 | |
Michael C Loebach, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1221 N Highland Ave, Aurora, IL 60506 Phone: 630-859-8700 | |
David Sarcu, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1221 N Highland Ave, Aurora, IL 60506 Phone: 630-859-8700 | |
Richard L Kersch, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1221 N Highland Ave, Aurora, IL 60506 Phone: 630-859-8700 | |
Michael Eggerstedt, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2040 Ogden Ave Ste 301, Aurora, IL 60504 Phone: 630-978-6895 |